The Management of Extravasation of Chemotherapy Agents

Extravasation is the leakage of fluids from a vein into the surrounding tissues and is a recognised complication of insertion of a cannula; one of the most common invasive procedures performed in hospitals.

The symptoms of extravasation injury can include pain, redness, swelling and blistering, but the damage can extend to involve nerves, tendons and joints. The most serious cases can require surgical debridement, skin grafting, and even amputation of the affected limb.

Some of the most serious extravasation injuries can occur with the administration of chemotherapy. Chemotherapy agents are cytotoxic in that they have anti-cancer activity, but also have the potential to cause tissue destruction if they extravasate into surrounding tissues when being administered.

Therefore, nurses who are cannulating and administering chemotherapy to patients should be comprehensively trained in the cannulation of patients for chemotherapy, and in the management of extravasation injuries when they occur.

In particular, some chemotherapy treatments involve administering several drugs at one time (for example FEC chemotherapy), and when extravasation occurs this should be treated in accordance with the procedures related to the drug which could cause the most damage to the patient. Thus, it is vital that nurses administering chemotherapy have an understanding of the nature of the drugs being administered and what procedure to select when extravasation occurs.

THEMIS Stand BOA 2025

THEMIS at the British Orthopaedic Association Conference 2025

This week, the THEMIS team had the pleasure of attending the British Orthopaedic Association (BOA) Conference in Liverpool, and it was an inspiring few days for everyone involved.

Read More
THEMIS Stand

THEMIS at the RCOG World Congress 2025

We’ve partnered with the RCOG on a number of occasions, and this event gave us another brilliant opportunity to reaffirm our long-term commitment to supporting those working in this discipline.

Read More
Themis Representative Meeting

THEMIS and QBE Forge Strategic Partnership to Shape the Future of Medical Malpractice Indemnity

THEMIS is pleased to announce a five-year capacity agreement with QBE, one of the world’s leading insurers. This partnership reflects a shared commitment to providing the healthcare sector with a stable, robust, and future-focused indemnity solution.

Read More